by boosting the effective availability of the translation initiator eif4e, mtorc1 activity promotes the translation of a number of "weak" mrnas that code for proteins, often up-regulated in cancer, that promote cellular proliferation, invasiveness, and angiogenesis, and that abet cancer promotion and chemoresistance by opposing apoptosis.